Botulinum toxin and fasciotens in the management of complex ventral hernia: a case report

Authors

  • Premkumar Balachandran Institute of Hernia Surgery and Abdominal Wall Reconstructions, Apollo Hospitals, Chennai, Tamil Nadu, India
  • Vishanth Gubendran Institute of Hernia Surgery and Abdominal Wall Reconstructions, Apollo Hospitals, Chennai, Tamil Nadu, India
  • T. S. Subbiah Institute of Hernia Surgery and Abdominal Wall Reconstructions, Apollo Hospitals, Chennai, Tamil Nadu, India
  • M. Kanagavel Isabel Hospitals, Chennai, Tamil Nadu, India
  • Sengutuvan Pandian Apollo Speciality Hospitals- OMR, Chennai, Tamil Nadu, India
  • Adhiyaman Department of General Surgery, Apollo Speciality Hospitals - OMR, Chennai, Tamil Nadu, India
  • Sabarigiri Easan Department of General Surgery, Madras Medical College, Chennai, Tamil Nadu, India
  • Kamalakannan Apollo Speciality Hospitals- OMR, Chennai, Tamil Nadu, India
  • Charles Mano Sylus Apollo Hospitals, Vanagram, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20250831

Keywords:

Complex ventral hernia, Loss of domain, Component separation, Botulinum toxin A, Intraoperative fascial tension

Abstract

The field of Abdominal wall reconstruction (AWR) has become globally popular in recent years due to various advancement in techniques. However, the management of complex ventral hernias (CVH) with loss of domain demands more attention and the learning curve for even experienced surgeons can be very high. The component separation techniques are widely used for complex ventral hernia repairs. Loss of domain hernias may require the necessity of combining component separation with other newer techniques such as Botulinum toxin A(BTA) administration and Fasciotens device. In this paper we highlight an interesting case of LOD hernia utilizing these techniques.

Metrics

Metrics Loading ...

Author Biography

Premkumar Balachandran, Institute of Hernia Surgery and Abdominal Wall Reconstructions, Apollo Hospitals, Chennai, Tamil Nadu, India

Dr. BALACHANDRAN PREMKUMAR

MBBS, MS, FRCS(Glas), M.MAS(UK), FICS,

FICRS, FIAGES, FAMASI, Dip. ALS, FALS

Senior Consultant Surgeon & Coordinator

Dept. of General, Gastrointestinal and Bariatric surgery

Apollo Speciality Hospital - OMR Chennai

Clinical Lead - Institutes of Hernia Surgery &

Abdominal Wall Reconstruction, Apollo Hospitals - Chennai

References

Chowbey P, Wadhawan R, Subramanian D, Bhandarkar D, Gandhi J. Ventral hernia repair in India: a Delphi consensus. Hernia. 2024;28(5):1511-23. DOI: https://doi.org/10.1007/s10029-024-03062-4

Parker SG, Halligan S, Blackburn S, Plumb AAO, Archer L, Mallett S, et al. What exactly is meant by "loss of domain" for ventral hernia? systematic review of definitions. World J Surg. 2019;43(2):396-404. DOI: https://doi.org/10.1007/s00268-018-4783-7

Tang FX, Ma N, Huang E, Ma T, Liu CX, Chen S, et al. Botulinum toxin A facilitated laparoscopic repair of complex ventral hernia. Front Sursg. 2022;8:803023. DOI: https://doi.org/10.3389/fsurg.2021.803023

Muysoms FE, Miserez M, Berrevoet F, Campanelli G, Champault GG, Chelala E, et al. Classification of primary and incisional abdominal wall hernias. hernia. 2009;13:407-14. DOI: https://doi.org/10.1007/s10029-009-0518-x

Sagar A, Tapuria N. An Evaluation of the Evidence Guiding Adult Midline Ventral Hernia Repair. Surg J (NY). 2022;8(3):145-56. DOI: https://doi.org/10.1055/s-0042-1749428

Lodha M, Patel D, Badkur M, Meena SP, Puranik A, Chaudhary R, et al. Assessment of Quality of Life after ventral hernia repair: a prospective observational study at a Tertiary Care Centre. Cureus. 2022;14(6):21356. DOI: https://doi.org/10.7759/cureus.26136

Bueno-Lledó J, Carreño-Saenz O, Torregrosa-Gallud A, Pous-Serrano S. Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias-our first 100 cases. Front Surg. 2020;7:3. DOI: https://doi.org/10.3389/fsurg.2020.00003

Parker SG, Halligan S, Liang MK, Muysoms FE, Adrales GL, Boutall A, et al. Definitions for loss of domain: an international Delphi consensus of expert surgeons. World J of Surg. 2020;44:1070-8. DOI: https://doi.org/10.1007/s00268-019-05317-z

Whitehead-Clarke T, Windsor A. The Use of Botulinum Toxin in Complex Hernia Surgery: Achieving a Sense of Closure. Front Surg. 2021;8:753889. DOI: https://doi.org/10.3389/fsurg.2021.753889

Mandujano CC, Lima DL, Alcabes A, Friedmann P, Pereira X, Malcher F. Preoperative botulinum A toxin as an adjunct for abdominal wall reconstruction: a single-center early experience at an Academic Center in New York. Rev Col Bras Cir. 2022;49:20213152. DOI: https://doi.org/10.1590/0100-6991e-20213152

Seretis F, Chrysikos D, Samolis A, Troupis T. Botulinum toxin in the surgical treatment of complex abdominal hernias: a surgical anatomy approach, current evidence and outcomes. In Vivo. 2021;35(4):1913-20. DOI: https://doi.org/10.21873/invivo.12457

Soltanizadeh S, Helgstrand F, Jorgensen LN. Botulinum Toxin A as an Adjunct to Abdominal Wall Reconstruction for Incisional Hernia. Plast Reconstr Surg Glob Open. 2017;5(6):1358. DOI: https://doi.org/10.1097/GOX.0000000000001358

Tenaudier M, Moszkowicz D, Passot G, Romain B, Perrenot C, Borraccino B, et al. Botulinum toxin injection before giant incisional hernia repair: Surgical technique. J Visc Surg. 2022;159(1):55-8. DOI: https://doi.org/10.1016/j.jviscsurg.2021.06.009

Bueno-Lledo J, Ibrahim N, Zielinski M. Editorial: Botox in Complex Abdominal Wall Surgery. Front Surg. 2022;9:900968. DOI: https://doi.org/10.3389/fsurg.2022.900968

Niebuhr H, Auffenberg T, Dag H, Reinpold W, Peiper C, Schardey HM, et al. Intraoperative Fascia Tension as an Alternative to Component Separation. A Prospective Observational Study. Front. Surg. 2021;7:616669. DOI: https://doi.org/10.3389/fsurg.2020.616669

Bloemendaal ALA. Case Report: Intraoperative Fascial Traction in Robotic Abdominal Wall Surgery; An Early Experience. J Abdominal Wall Surg. 2022;1:10356. DOI: https://doi.org/10.3389/jaws.2022.10356

Dohmen J, Weissinger D, Peter AS, Theodorou A, Kalff JC, Stoffels B, et al. Evaluating a novel vertical traction device for early closure in open abdomen management: a consecutive case series. Front Surg. 2024;11:1449702. DOI: https://doi.org/10.3389/fsurg.2024.1449702

Gorjanc J, Dreschl C, Trieb S, Greiner M, Grün A, Zanchi P, et al. The use of intraoperative fascial traction in W3-incisional hernia repair: A revolution or an emergency exit (two case reports). International Journal of Abdominal Wall and Hernia Surgery. 2023;6(3):186-92. DOI: https://doi.org/10.4103/ijawhs.IJAWHS_17_23

Niebuhr H, Wegner F, Dag H, Reinpold W, Woeste G, Köckerling F. Preoperative botulinum toxin A (BTA) and intraoperative fascial traction (IFT) in the management of complex abdominal wall hernias. Hernia. 2024;28(6):2273-83. DOI: https://doi.org/10.1007/s10029-024-03156-z

Downloads

Published

2025-03-26

How to Cite

Balachandran, P., Gubendran, V., Subbiah, T. S., Kanagavel, M., Pandian, S., Adhiyaman, Easan, S., Kamalakannan, & Mano Sylus, C. (2025). Botulinum toxin and fasciotens in the management of complex ventral hernia: a case report. International Surgery Journal, 12(4), 651–656. https://doi.org/10.18203/2349-2902.isj20250831

Issue

Section

Case Reports